A Synthesis of “Dual Warhead” β‑Aryl Ethenesulfonyl Fluorides and One-Pot Reaction to β‑Sultams

by Chinthakindi, Praveen K   Govender, Kimberleigh B   Kumar, A. Sanjeeva   Kruger, Hendrik G   Govender, Thavendran   Naicker, Tricia   Arvidsson, Per I Published in Organic letters (03.02.2017)

Mapping routine measles vaccination in low- and middle-income countries

by Abbas, KM   Abdollahi, M   Abushouk, AI   Adebayo, OM   Aghaali, M   Alcalde-Rabanal, JE   Alijanzadeh, M   Alinia, C   Almasi-Hashiani, A   Al-Mekhlafi, HM   Amare, B   Armoon, B   Aryal, KK   Asadi-Aliabadi, M   Asgari, S   Quintanilla, BPA   Aynalem, YA   Babaee, E   Behzadifar, M   Birhanu, M   Briko, AN   Campos-Nonato, IR   Cardenas, R   Castro, F   Chehrazi, M   Chin, KL   Chu, DT   Dansereau, E   Darwish, AH   De Neve, JW   Demeke, FM   Dhungana, GP   Dipeolu, IO   Do, HT   Doshmangir, L   Leylabadlo, HE   Elhabashy, HR   Esteghamati, A   Gebrehiwot, TT   Ghadiri, K   Gheshlagh, RG   Ghiasvand, H   Hasanpoor, E   Hassanipour, S   Hosseinzadeh, M   Hu, GQ   Humayun, A   Karyani, AK   Khan, MS   Khater, MM   Lam, F   Lansingh, VC   Lasrado, S   Lee, PH   Mahdavi, MM   Maleki, S   Mansouri, B   Mayala, BK   Miller-Petrie, MK   Mirrakhimov, EM   Mirzaei, HR   Mohammad, DK   Moradi, G   Naderi, M   Nazari, J   Nigatu, YT   Nikpoor, AR   Olusanya, BO   Pana, A   Pescarini, JM   Postma, MJ   Rabiee, M   Ramezanzadeh, K   Reshmi, B   Rezaei, N   Rezapour, A   Rwegerera, GM   Sahraian, MA   Sarmiento-Suarez, R   Sathish, T   Siddiqi, TJ   Sinha, DN   Soyiri, IN   Spurlock, EE   Suleria, HAR   Taveira, N   Unnikrishnan, B   Upadhyay, E   Waheed, Y   Wang, YP   Weldesamuel, GT   Westerman, R   Wiens, KE   Yousefi, Z   Yousefinezhadi, T   Zamani, M   Zandian, H   Zhang, ZJ   Zhou, MG   Hay, SI Published in Nature (London) (2021)

A Prospective Phase 2 Study to Assess Minimal Residual Disease after Ixazomib, Lenalidomide and Dexamethasone Treatment for Newly Diagnosed Transplant Eligible Multiple Myeloma Pat...

by Silvennoinen, Raija Helena   Waage, Anders   Peceliunas, Valdas   Schjesvold, Fredrik   Anttila, Pekka   Säily, Marjaana   Putkonen, Mervi   Carlson, Kristina   Haukaas, Einar   Sankelo, Marja   Partanen, Anu   Szatkowski, Damian L   Hansson, Markus   Marttila, Anu   Ahlberg, Lucia   Axelsson, Per   Lauri, Birgitta   Mikkola, Maija Helena   Karlsson, Conny   Abelsson, Johanna   Ahlstrand, Erik   Sikiö, Anu   Klimkowska, Monika   Matuzeviciene, Reda   Hoysaeter Fenstad, Mona   Ilveskero, Sorella   Nahi, Hareth Published in Blood (05.11.2020)

Updated Phase 1 Results of Teclistamab, a B-Cell Maturation Antigen (BCMA) x CD3 Bispecific Antibody, in Relapsed and/or Refractory Multiple Myeloma (RRMM)

by Garfall, Alfred L   Usmani, Saad Z   Mateos, María-Victoria   Nahi, Hareth   van de Donk, Niels W.C.J   San-Miguel, Jesus F   Oriol Rocafiguera, Albert   Rosinol, Laura   Chari, Ajai   Bhutani, Manisha   Pei, Lixia   Verona, Raluca   Girgis, Suzette   Stephenson, Tara   Goldberg, Jenna D   Banerjee, Arnob   Krishnan, Amrita Published in Blood (05.11.2020)

Reply

by Zetterberg, M   Kugelberg, M   Nilsson, I   Lundstrom, M   Behndig, A   Montan, P Published in Ophthalmology (Rochester, Minn.) (2021)

Machine-Learning Prediction of Comorbid Substance Use Disorders in ADHD Youth Using Swedish Registry Data

by Zhang-James, Yanli   Chen, Qi   Kuja-Halkola, Ralf   Lichtenstein, Paul   Larsson, Henrik   Faraone, Stephen V Published in Journal of child psychology and psychiatry (06.06.2019)

Omitting completion axillary lymph node dissection after sentinel node micrometastases in breast cancer – first results from the Swedish prospective SENOMIC trial

by Andersson, Y   Bergkvist, L   Frisell, J   de Boniface, J Published in European journal of cancer (1990) (01.10.2020)

Do clinical trials truly mirror their target population? An external validity analysis of national register versus trial data from the Swedish prospective SENOMIC trial on sentinel...

by Andersson, Y   Frisell, J   Bergkvist, L   de Boniface, J Published in European journal of cancer (1990) (01.10.2020)

Long-term prognosis is associated with residual disease after neoadjuvant systemic therapy but not with initial nodal status

by Zetterlund, L   Celebioglu, F   Frisell, J   de Boniface, J Published in European journal of cancer (1990) (01.10.2020)

The generalisability of randomised clinical trials: An interim external validity analysis of the ongoing SENOMAC trial in sentinel lymph node-positive breast cancer

by De Boniface, J   Ahlgren, J   Andersson, Y   Bergkvist, L   Frisell, J   Lundstedt, D   Bagge, R.Olofsson   Rydén, L   Sund, M Published in European journal of cancer (1990) (01.10.2020)